Locke Bio Enables Emerging E-Commerce Brands To Sell Prescription Drugs Direct-To-Consumer

Locke Bio, a digital health platform company, announced a new offering targeted at emerging e-commerce and telehealth brand owners who want to expand their offering to include prescription drugs. The solution offers a streamlined platform experience at an affordable price point, starting at $1,500 per month, to enable smaller e-commerce companies to gain a foothold in this market.

The new solution gives e-commerce brands access to Locke Bio's white-labeled platform, including customized consumer intake onboarding, e-commerce payment processing, and more. Companies will also have access to Locke Bio's expansive U.S. and . . .